180 related articles for article (PubMed ID: 37996129)
1. Development and external validation of a prediction model for venous thromboembolism in systemic lupus erythematosus.
You H; Zhao J; Zhang M; Jin Z; Feng X; Tan W; Wu L; Duan X; Luo H; Zhao C; Zhan F; Wu Z; Li H; Yang M; Xu J; Wei W; Wang Y; Shi J; Qu J; Wang Q; Leng X; Tian X; Zhao Y; Li M; Zeng X
RMD Open; 2023 Nov; 9(4):. PubMed ID: 37996129
[TBL] [Abstract][Full Text] [Related]
2. Long-term incidence, risk factors and complications for venous thromboembolism in patients with systemic lupus erythematosus.
Nossent JC; Keen HI; Preen DB; Inderjeeth CA
Lupus; 2024 Jul; 33(8):787-796. PubMed ID: 38655753
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive bioinformatics analysis reveals the crosstalk genes and immune relationship between the systemic lupus erythematosus and venous thromboembolism.
Yu J; Yang J; He Q; Zhang Z; Xu G
Front Immunol; 2023; 14():1196064. PubMed ID: 37465678
[TBL] [Abstract][Full Text] [Related]
4. Venous thromboembolism in southern Chinese patients with systemic lupus erythematosus.
Mok CC; Ho LY; Yu KL; To CH
Clin Rheumatol; 2010 Jun; 29(6):599-604. PubMed ID: 20101427
[TBL] [Abstract][Full Text] [Related]
5. Practical Utility of D-dimer Test for Venous Thromboembolism in Systemic Lupus Erythematosus Depends on Disease Activity: a Retrospective Cohort Study.
Oh YJ; Park EH; Park JW; Song YW; Lee EB
J Korean Med Sci; 2020 Nov; 35(43):e356. PubMed ID: 33169554
[TBL] [Abstract][Full Text] [Related]
6. Venous Thromboembolic Events in African American Lupus Patients in Association With Antiphospholipid Antibodies Compared to White Patients.
Gkrouzman E; Peng M; Davis-Porada J; Kirou KA
Arthritis Care Res (Hoboken); 2022 Apr; 74(4):656-664. PubMed ID: 33171010
[TBL] [Abstract][Full Text] [Related]
7. Risk Assessment Model for Postpartum Venous Thromboembolism Prevention in Patients with Systemic Lupus Erythematosus.
Griffin MM; Engel A; Mehta-Lee SS; Nusbaum J; Golpanian M; Izmirly P; Belmont HM; Buyon JP
Am J Perinatol; 2023 Dec; 40(16):1732-1737. PubMed ID: 37494484
[TBL] [Abstract][Full Text] [Related]
8. Predicting the Risk of Pulmonary Arterial Hypertension in Systemic Lupus Erythematosus: A Chinese Systemic Lupus Erythematosus Treatment and Research Group Cohort Study.
Qu J; Li M; Wang Y; Duan X; Luo H; Zhao C; Zhan F; Wu Z; Li H; Yang M; Xu J; Wei W; Wu L; Liu Y; You H; Qian J; Yang X; Huang C; Zhao J; Wang Q; Leng X; Tian X; Zhao Y; Zeng X
Arthritis Rheumatol; 2021 Oct; 73(10):1847-1855. PubMed ID: 34105259
[TBL] [Abstract][Full Text] [Related]
9. Venous and Arterial Thrombotic Events in Systemic Lupus Erythematosus.
Hinojosa-Azaola A; Romero-Diaz J; Vargas-Ruiz AG; Nuñez-Alvarez CA; Cicero-Casarrubias A; Ocampo-Torres MC; Sanchez-Guerrero J
J Rheumatol; 2016 Mar; 43(3):576-86. PubMed ID: 26773122
[TBL] [Abstract][Full Text] [Related]
10. Cutaneous lupus erythematosus and the risk of deep venous thrombosis and pulmonary embolism: A Danish nationwide cohort study.
Ahlehoff O; Wu JJ; Raunsø J; Kristensen SL; Khalid U; Kofoed K; Gislason G
Lupus; 2017 Nov; 26(13):1435-1439. PubMed ID: 28618892
[TBL] [Abstract][Full Text] [Related]
11. The risk of pulmonary embolism and deep venous thrombosis in systemic lupus erythematosus: A general population-based study.
Aviña-Zubieta JA; Vostretsova K; De Vera MA; Sayre EC; Choi HK
Semin Arthritis Rheum; 2015 Oct; 45(2):195-201. PubMed ID: 26364556
[TBL] [Abstract][Full Text] [Related]
12. The contribution of inherited and acquired thrombophilic defects, alone or combined with antiphospholipid antibodies, to venous and arterial thromboembolism in patients with systemic lupus erythematosus.
Brouwer JL; Bijl M; Veeger NJ; Kluin-Nelemans HC; van der Meer J
Blood; 2004 Jul; 104(1):143-8. PubMed ID: 15026314
[TBL] [Abstract][Full Text] [Related]
13. Machine learning algorithm as a prognostic tool for venous thromboembolism in allogeneic transplant patients.
Deng RX; Zhu XL; Zhang AB; He Y; Fu HX; Wang FR; Mo XD; Wang Y; Zhao XY; Zhang YY; Han W; Chen H; Chen Y; Yan CH; Wang JZ; Han TT; Chen YH; Chang YJ; Xu LP; Huang XJ; Zhang XH
Transplant Cell Ther; 2023 Jan; 29(1):57.e1-57.e10. PubMed ID: 36272528
[TBL] [Abstract][Full Text] [Related]
14. Associations with thrombosis are stronger for antiphosphatidylserine/prothrombin antibodies than for the Sydney criteria antiphospholipid antibody tests in SLE.
Elbagir S; Grosso G; Mohammed NA; Elshafie AI; Elagib EM; Zickert A; Manivel VA; Pertsinidou E; Nur MAM; Gunnarsson I; Rönnelid J; Svenungsson E
Lupus; 2021 Jul; 30(8):1289-1299. PubMed ID: 33957795
[TBL] [Abstract][Full Text] [Related]
15. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
Danowski A; de Azevedo MN; de Souza Papi JA; Petri M
J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935
[TBL] [Abstract][Full Text] [Related]
16. Antiphospholipid antibodies and incidence of venous thrombosis in a cohort of patients with systemic lupus erythematosus.
Somers E; Magder LS; Petri M
J Rheumatol; 2002 Dec; 29(12):2531-6. PubMed ID: 12465147
[TBL] [Abstract][Full Text] [Related]
17. Risk assessment of venous thromboembolism in head and neck cancer patients and its establishment of a prediction model.
Li CX; He Q; Wang ZY; Fang C; Gong ZC; Zhao HR; Ling B
Head Neck; 2023 Oct; 45(10):2515-2524. PubMed ID: 37548087
[TBL] [Abstract][Full Text] [Related]
18. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA). XXV. Smoking, older age, disease activity, lupus anticoagulant, and glucocorticoid dose as risk factors for the occurrence of venous thrombosis in lupus patients.
Calvo-Alén J; Toloza SM; Fernández M; Bastian HM; Fessler BJ; Roseman JM; McGwin G; Vilá LM; Reveille JD; Alarcón GS;
Arthritis Rheum; 2005 Jul; 52(7):2060-8. PubMed ID: 15986376
[TBL] [Abstract][Full Text] [Related]
19. A predictive model for premature atherosclerosis in systemic lupus erythematosus based on clinical characteristics.
Liang R; Xu H; Yao R; Pei W; Wang Z; Liang R; Han X; Zhou Y; An Y; Su Y
Clin Rheumatol; 2024 May; 43(5):1541-1550. PubMed ID: 38565803
[TBL] [Abstract][Full Text] [Related]
20. Acquired activated protein C resistance is associated with the co-existence of anti-prothrombin antibodies and lupus anticoagulant activity in patients with systemic lupus erythematosus.
Nojima J; Kuratsune H; Suehisa E; Kawasaki T; Machii T; Kitani T; Iwatani Y; Kanakura Y
Br J Haematol; 2002 Aug; 118(2):577-83. PubMed ID: 12139749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
